Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease

[1]  C. Nau,et al.  Ocular Graft-Versus-Host Disease: A Review , 2015, Eye & contact lens.

[2]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[3]  H. Lokhorst,et al.  Impact of ocular graft‐versus‐host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study , 2014, Acta ophthalmologica.

[4]  N. Kasetsuwan,et al.  Incidence and Pattern of Dry Eye after Cataract Surgery , 2013, PloS one.

[5]  A. Romphruk,et al.  Contamination Risk of 100% Autologous Serum Eye Drops in Management of Ocular Surface Diseases , 2013, Cornea.

[6]  E. Akpek,et al.  Ocular graft-versus-host disease , 2012, Current opinion in allergy and clinical immunology.

[7]  M. Flowers,et al.  Visual Acuity and Anterior Segment Findings in Chronic Graft-Versus-Host Disease , 2011, Cornea.

[8]  Y. Gami,et al.  Posterior capsule opacification in eyes with steroid‐induced cataracts: Comparison of early results , 2011, Journal of cataract and refractive surgery.

[9]  A. Gratwohl,et al.  Hematopoietic stem cell transplantation: a global perspective. , 2010, JAMA.

[10]  G. Kemmler,et al.  Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation , 2010, Bone Marrow Transplantation.

[11]  B. Bauer,et al.  Cataract patients in a defined Swedish population 1986–1990 , 2009 .

[12]  T. Gondhowiardjo,et al.  Sensitivity Change in Cornea and Tear Layer due to Incision Difference on Cataract Surgery with Either Manual Small-Incision Cataract Surgery or Phacoemulsification , 2008, Cornea.

[13]  W. Wang,et al.  Investigation of Dry Eye Disease and Analysis of the Pathogenic Factors in Patients after Cataract Surgery , 2007, Cornea.

[14]  Thomas C Prager,et al.  Classifying the Severity of Corneal Ulcers by Using the “1, 2, 3” Rule , 2007, Cornea.

[15]  J. Dowler,et al.  Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients , 2006, Clinical & experimental ophthalmology.

[16]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  A. Vasavada,et al.  Intraoperative performance and longterm outcome of phacoemulsification in age-related cataract. , 2004, Indian journal of ophthalmology.

[18]  C. McGhee,et al.  The Auckland Cataract Study: 2 year postoperative assessment of aspects of clinical, visual, corneal topographic and satisfaction outcomes , 2004, British Journal of Ophthalmology.

[19]  H. Dua,et al.  A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders , 2004, British Journal of Ophthalmology.

[20]  T. Oshika,et al.  Cumulative probability of neodymium:YAG laser posterior capsulotomy after phacoemulsification , 2003, Journal of cataract and refractive surgery.

[21]  J. Ram,et al.  Outcomes of phacoemulsification in patients with dry eye , 2002, Journal of cataract and refractive surgery.

[22]  K. Soong,et al.  Cataract surgery in allogeneic bone marrow transplant recipients with graft‐versus‐host disease , 2002, Journal of cataract and refractive surgery.

[23]  M. Dana,et al.  Phacoemulsification in patients after allogeneic bone marrow transplantation. , 2001, Ophthalmology.

[24]  D. Apple,et al.  Eradication of posterior capsule opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. , 2001, Ophthalmology.

[25]  D. Hodge,et al.  Probability of Nd:YAG laser capsulotomy after cataract surgery in Olmsted County, Minnesota. , 2001, American journal of ophthalmology.

[26]  J. Battermann,et al.  Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters. , 2000, International journal of radiation oncology, biology, physics.

[27]  M R Dana,et al.  A systematic overview of the incidence of posterior capsule opacification. , 1998, Ophthalmology.

[28]  M. Labopin,et al.  Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. , 1998, International journal of radiation oncology, biology, physics.

[29]  R. Cumming,et al.  Prevalence of cataract in Australia: the Blue Mountains eye study. , 1997, Ophthalmology.

[30]  K. Sullivan,et al.  Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. , 1995, International journal of radiation oncology, biology, physics.

[31]  D. Jabs,et al.  Bone marrow transplantation and cataract development. , 1993, Archives of ophthalmology.

[32]  R. Wainsztein,et al.  Incidence of postoperative posterior capsular opacification with types of senile cataracts , 1992, Journal of cataract and refractive surgery.

[33]  I. Crocker,et al.  Bone marrow transplant retinopathy. , 1991, American journal of ophthalmology.

[34]  S. Proctor,et al.  Ocular complications of bone marrow transplantation. , 1991, The British journal of ophthalmology.

[35]  J. H. Elliott,et al.  Sterile Corneal Ulceration after Cataract Extraction in Patients with Collagen Vascular Disease , 1990, Cornea.

[36]  H. Deeg,et al.  Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. , 1984, International journal of radiation oncology, biology, physics.

[37]  K. Cohen.  Sterile corneal perforation after cataract surgery in Sjögren's syndrome. , 1982, The British journal of ophthalmology.

[38]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[39]  B. Bauer,et al.  Cataract patients in a defined Swedish population 1986-1990. VI. YAG laser capsulotomies in relation to preoperative and surgical conditions. , 1997, Acta ophthalmologica Scandinavica.

[40]  M. C. Leske,et al.  Prevalence of lens opacities in the Barbados Eye Study. , 1997, Archives of ophthalmology.

[41]  R. Storb,et al.  Indications for marrow transplantation. , 1984, Annual review of medicine.